EUVIMEDEUVIMED entdecken
Open Access

Symptomatic and Asymptomatic Norovirus Infections in Early Life; the PREVAIL Cohort, 2017–2020

Julia M Baker iD, Jennifer L Cannon, Claire P Mattison, Hannah Browne, Kenny Nguyen iD, Rachel M Burke iD, Eddie Bartlett, Shannon C Conrey iD, Allison R Burrell iD, Mary Allen Staat, Ardythe L Morrow, Umesh D Parashar und 3 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Julia M Baker und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Caliciviridae Infections, Norovirus, Gastroenteritis, Asymptomatic Infections. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAID NIH HHS, Good Ventures Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Norovirus is the leading cause of medically attended acute gastroenteritis in the United States. Efforts to reduce the disease burden are constrained by uncertainty around fundamental aspects of norovirus epidemiology. This study describes characteristics of norovirus infections and explores potential risk factors for symptomatic infections in early life.

Methods

The Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis Longitudinal (PREVAIL) birth cohort study followed 245 children from birth to 2 years of age with weekly stool sample collection and symptom surveys. Stool samples were tested by reverse transcriptase-realtime polymerase chain reaction to detect norovirus genogroup (G)I and GII; positive samples were genotyped. Infections accompanied by diarrhea and/or vomiting were considered symptomatic. Children were categorized as adherent if they participated for ≥18 months and submitted ≥70% of samples.

Results

A total of 72 GI and 330 GII norovirus infections (among 156 children) were identified. One-fifth (20.8%) of adherent children experienced ≥1 norovirus infection by 6 months of age, increasing to 84.2% of children by 2 years of age. About one-third of infections were symptomatic, including half of infections with cycle threshold values <25. Infection with norovirus genotype GII.4 Sydney was the strongest predictor of symptomatic infection in adjusted analyses, as was older age and higher viral load. Childcare attendance, breastfeeding, mother's secretor status, and prior infections were not predictive of symptom status.

Conclusions

This study highlights fundamental characteristics of norovirus epidemiology in early life with implications for understanding the full natural history of the disease, disease transmission, and prevention approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caliciviridae InfectionsNorovirusGastroenteritisAsymptomatic InfectionsHumansInfantFemaleMaleChild, PreschoolFecesInfant, NewbornGenotypeUnited StatesRisk FactorsLongitudinal StudiesCohort StudiesBirth CohortDiarrhea

Stichwörter der Autor:innen

United Statesbirth cohortchildgastroenteritisnorovirus

Autor:innen und Institutionen

  • Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • CDC Foundation, Atlanta, Georgia, USA.
  • Cherokee Nation Operational Solutions, Cherokee Federal, Tulsa, Oklahoma, USA.
  • Department of Environmental and Public Health Sciences, Division of Epidemiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Julia M Baker, Kenny Nguyen, Rachel M Burke, Shannon C Conrey, Allison R Burrell, Sara A Mirza

Förderung

  • NCATS NIH HHS
  • NIAID NIH HHS
  • Good Ventures Foundation
  • US Centers for Disease Control and Prevention
  • NIEHS NIH HHS
  • NCIRD CDC HHS
  • NIEHS
  • NIAID

Zitieren

APA

Baker, J. M., Cannon, J. L., Mattison, C. P., Browne, H., Nguyen, K., Burke, R. M., Bartlett, E., Conrey, S. C., Burrell, A. R., Staat, M. A., Morrow, A. L., Parashar, U. D., Vinjé, J., Mirza, S. A., & Payne, D. C. (2026). Symptomatic and Asymptomatic Norovirus Infections in Early Life; the PREVAIL Cohort, 2017–2020. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag033

Vancouver

Baker JM, Cannon JL, Mattison CP, Browne H, Nguyen K, Burke RM, et al. Symptomatic and Asymptomatic Norovirus Infections in Early Life; the PREVAIL Cohort, 2017–2020. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag033

BibTeX
@article{Baker2026,
  author = {Baker, Julia M and Cannon, Jennifer L and Mattison, Claire P and Browne, Hannah and Nguyen, Kenny and Burke, Rachel M and Bartlett, Eddie and Conrey, Shannon C and Burrell, Allison R and Staat, Mary Allen and Morrow, Ardythe L and Parashar, Umesh D and Vinjé, Jan and Mirza, Sara A and Payne, Daniel C},
  title = {Symptomatic and Asymptomatic Norovirus Infections in Early Life; the PREVAIL Cohort, 2017–2020},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag033}
}
Kostenlos starten →